Detalhe da pesquisa
1.
Real-world use and clinical impact of an electronic patient-reported outcome tool in patients with solid tumors treated with immuno-oncology therapy.
J Patient Rep Outcomes
; 8(1): 23, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416270
2.
Impact of clinical pathways on treatment patterns and outcomes for patients with non-small-cell lung cancer: real-world evidence from a community oncology practice.
J Comp Eff Res
; 11(8): 609-619, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35546311
3.
American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.
J Clin Oncol
; 39(2): 155-169, 2021 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33290128
4.
Why EOM participation was extremely low-and how to fix it.
Am J Manag Care
; 29(9 Spec No.): SP880-SP882, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38373090
5.
Time to Rethink the Role of Clinical Pathways in the Era of Precision Medicine: A Lung Cancer Case Study.
JCO Oncol Pract
; 17(7): 379-381, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872069
6.
A phase I/II study of exisulind in combination with docetaxel/carboplatin in patients with metastatic non-small-cell lung cancer.
Clin Lung Cancer
; 6(6): 361-6, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15943897
7.
Single-agent gefitinib in patients with untreated advanced non-small-cell lung cancer and poor performance status: a Minnie Pearl Cancer Research Network Phase II Trial.
Clin Lung Cancer
; 7(2): 127-32, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16179100
8.
Insights From the Oncology Care First Proposal-Where We've Been and Where We're Going in Value-Based Care.
JCO Oncol Pract
; 16(4): 151-153, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32097082
9.
Use of a Case Management System to Reduce the Response Time for Symptom Management Calls in a High-Volume Practice.
J Oncol Pract
; 12(10): 851-854, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27577615
10.
A phase II trial of neoadjuvant gemcitabine, epirubicin, and docetaxel as primary treatment of patients with locally advanced or inflammatory breast cancer.
Clin Breast Cancer
; 10(3): 217-23, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20497920